Header Ads

USFDA grants orphan drug status to mexiletine hydrochloride: Lupin

USFDA grants orphan drug status to mexiletine hydrochloride: Lupin The Mumbai-based company#39;s drug NaMuscula (mexiletine hydrochloride) is the first and only licensed product to treat myotonia in adults with non-dystrophic myotonic (NDM) disorders.

from Moneycontrol Business News https://ift.tt/30iAahr

No comments:

Powered by Blogger.